Medications are finely-tuned mechanisms to help treat a variety of issues, both short-term ailments and long-term illnesses. However, has the thought ever crossed your mind of how the drug knows exactly what to target in your body? The answer is the method of drug delivery. Through this method, a drug can be engineered that not only creates a map to the target of the therapy, but also to release in a specific pattern for ideal results. The concept has not only helped patients and improved the success of medications, but through research, it has also given a greater insight into the body’s circulatory system and how drugs can enter cells and tissues.
Drug delivery is an incredible advancement that creates a better experience by whoever has taken a specific medicine. By targeting the source or area of whatever issue the medication is meant to treat, people are likely to experience less side effects because the medicine is not circulating throughout the entire body and likely reaching areas where it is not needed and can have no positive impact. As with any field, there are still advancements being made and much to learn about the body and about medicine as more information is discovered and learned. When the concept of drug delivery was still in its early years, scientists learned about how altering a drug requires many parameters to be set and can affect dosage, but despite any drawbacks that affected the process, the knowledge that these formulas could be altered to create targeted and even more beneficial therapies was far too important to not continue researching.
The drug delivery industry, currently valued at $1.23 trillion globally, is far from complete. There are still medications that do not quite work in this format and may still cause heightened side effects or may not reach only the areas that they are targeting. However, the baselines that have been established are always being expanded, and each phase builds on the previous one to create drugs with more successful delivery rates. These can also be used to determine how existing drugs can then have a delivery method applied to them. New diseases are often discovered, so these advancements will help scientists stay ahead of life-threatening developments and be prepared for when a targeted therapy is needed. There are even hopes that targeted drug deliveries will eventually go hand-in-hand to create a single step of diagnosis and treatment. These exciting new opportunities make it clear why the industry is forecasted to reach a worth of $2.13 trillion globally by the year 2028.
Drug delivery is an integral part of the pharmaceutical industry, and though it has been around for many years, there is still much more to learn and refine. Make sure you are part of those discoveries, and check out our inventory of Solid Dose equipment and Biopharmaceutical equipment. You can also contact us today if there is something specific you are looking to purchase or if you have surplus equipment you would like to sell.
Previous Entries in Our Pharmaceutical Packaging Series